These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis. Pollheimer MJ; Fickert P; Stieger B Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039 [TBL] [Abstract][Full Text] [Related]
3. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2 Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037 [TBL] [Abstract][Full Text] [Related]
4. Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults. Omenetti A; Yang L; Gainetdinov RR; Guy CD; Choi SS; Chen W; Caron MG; Diehl AM Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G303-15. PubMed ID: 21071507 [TBL] [Abstract][Full Text] [Related]
5. Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y Lab Invest; 2010 Jun; 90(6):835-43. PubMed ID: 20212459 [TBL] [Abstract][Full Text] [Related]
6. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target. Trussoni CE; O'Hara SP; LaRusso NF Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659 [TBL] [Abstract][Full Text] [Related]
7. TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. Bird TG; Müller M; Boulter L; Vincent DF; Ridgway RA; Lopez-Guadamillas E; Lu WY; Jamieson T; Govaere O; Campbell AD; Ferreira-Gonzalez S; Cole AM; Hay T; Simpson KJ; Clark W; Hedley A; Clarke M; Gentaz P; Nixon C; Bryce S; Kiourtis C; Sprangers J; Nibbs RJB; Van Rooijen N; Bartholin L; McGreal SR; Apte U; Barry ST; Iredale JP; Clarke AR; Serrano M; Roskams TA; Sansom OJ; Forbes SJ Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111642 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis. Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096 [TBL] [Abstract][Full Text] [Related]
9. Knockout of the Tachykinin Receptor 1 in the Mdr2 Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019 [TBL] [Abstract][Full Text] [Related]
10. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Chung BK; Karlsen TH; Folseraas T Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951 [TBL] [Abstract][Full Text] [Related]
11. The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence. Wu N; Meng F; Zhou T; Venter J; Giang TK; Kyritsi K; Wu C; Alvaro D; Onori P; Mancinelli R; Gaudio E; Francis H; Alpini G; Glaser S; Franchitto A Am J Pathol; 2018 Oct; 188(10):2264-2280. PubMed ID: 30036520 [TBL] [Abstract][Full Text] [Related]
12. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Lu WY; Bird TG; Boulter L; Tsuchiya A; Cole AM; Hay T; Guest RV; Wojtacha D; Man TY; Mackinnon A; Ridgway RA; Kendall T; Williams MJ; Jamieson T; Raven A; Hay DC; Iredale JP; Clarke AR; Sansom OJ; Forbes SJ Nat Cell Biol; 2015 Aug; 17(8):971-983. PubMed ID: 26192438 [TBL] [Abstract][Full Text] [Related]
13. Functional role of cellular senescence in biliary injury. Meng L; Quezada M; Levine P; Han Y; McDaniel K; Zhou T; Lin E; Glaser S; Meng F; Francis H; Alpini G Am J Pathol; 2015 Mar; 185(3):602-9. PubMed ID: 25619959 [TBL] [Abstract][Full Text] [Related]
14. An update on the management of cholestatic liver diseases. Appanna G; Kallis Y Clin Med (Lond); 2020 Sep; 20(5):513-516. PubMed ID: 32934048 [TBL] [Abstract][Full Text] [Related]